Verum Diagnostics Inc

PhD in Biochemistry Accomplished serial entrepreneur >30y pharmaceutical executive experience. PhD in Computer Science Co-founder 15 years experience in systems biology. MSc in Business AdministrationCo-founder Planning, controlling and managing all financial, legal and critical operational activities of the company. PhD in Biochemistry8 years cellular biology, cell signaling and pharmacology. PhD with dual Biology-MSc Computation-MSc background14 years research experience in structural and systems biology.

We are a start-up originally spun out of Dr. Dhivya is a passionate Entrepreneur with 15+ years experience in defining winning strategies and building high performance teams. Vergara has 14+ years of experience in experimental and computational biology. Shellard has a PhD and 12+ years of experience in cell biology and live imaging. Brian brings a track record of leading teams to deliver transformative results for clients across the healthcare sector at McKinsey and Company with particular focus on strategy / corporate finance, go-to-market, and M&A. Laghrissi is the CEO of DalCor Pharmaceuticals and has more than 20 years of pharmaceutical industry leadership experience, including roles at AstraZeneca, Roche, HBA and WPIC. Kupfer is the ex-Head of the DSM-5 plan committee, and has expert knowledge of the current principal manual for psychiatric & neurocognitive diagnosis, as recommended by the American Psychiatric Association. Linder is the CEO at Calciscon AG, biomedical consultant, entrepreneur & senior biotech executive with track record of success for biomedical devices.

Ahmad is a trained internist and clinical oncologist and brings over two decades of successful strategic clinical development, medical affairs, and marketing authorization expertise. Zocca brings more than 18 years of experience in the biotechnology field and has participated in the founding and co-founding of several biotech spinouts. Sullivan is a seasoned life sciences professional with more than 25 years of experience raising capital and building and managing corporate biotechnology and life sciences brands. Faulkner brings more than 25 years of technical operations, quality, and product launch experience within the biotechnology industry. Faulkner has experience in product development, manufacturing operations, supply chain, and commercialization of peptides, proteins, monoclonal antibodies, viruses, and combination products. Faulkner held senior roles at Homology Medicines as head of CMC management and external manufacturing, product operations lead for the Rare Disease Business Unit at Shire (Takeda), and spent over 15 years at Biogen involved in the development and commercialization of Avonex®, Tysabri®, and Tecfidera®. Dhingra is a medical oncologist and a physician-scientist with a proven track record in academic research, patient care, and drug development. Dhingra founded KAPital Consulting, LLC in 2008, a company dedicated to helping biotechnology, pharmaceutical, and diagnostic companies realize the clinical and commercial advances in oncology.

We are always looking for outstanding scientists who share our passion for scientific innovation and are guided by our core values. Cherrington also has extensive experience building and leading biotechnology companies. Steve Vicik has more than 25 years of experience in pharmaceutical process and product development, manufacturing operations, and supply chain design & distribution for large and small molecule drugs. Steve is also the holder of several large molecule manufacturing patents, delivered numerous product lifecycle enhancements to improve operational efficiency or enhance the patient experience, and has managed multiple partnerships with both pharmaceutical and medical device companies. Algaze has nearly 20 years of experience in the biotech industry, specializing in Financial Planning, Alliance Management, Clinical Business Management, and Controllership. Cesano provides recommendations on both choice of therapeutic indications and mechanistic & prognostic biomarker strategies to Actym. Cesano is the Chief Medical Officer at ESSA Pharma, since July 2019. William Lu, PhD, is the Associate Director of Translational Sciences at Actym Therapeutics.

He has over 20 years of experience in biomedical R&D in academia (NIH) and biotech and pharma companies (Amgen, Pfizer). Over the last 15 years, he has raised > 20 M Euros in capital and R&D grants. He has been instrumental in developing Biosystems’ technology and product candidates. A former lawyer at a BIG4 law firm and specialized in transactions, corporate, and competition law, she has been advising BSI since its latest investment round. Co-Founder of Biosystems, Director of Marketing and Sales.

Our experts go beyond providing strategy and advice; we execute and deliver to ensure your organization’s success. With over 20 years’ experience in the biotech industry, Brandy is a trusted partner for life science organizations, providing advice, expertise, and problem-solving to teams during times of tremendous growth. Dan has over 15 years of experience including various roles in operational, quality, engineering and project management/execution in support of the drug manufacturing and life sciences industries with a focus on mission-critical systems. Tom is a driving force in achieving both internal and external goals, including achievement of revenue, client satisfaction, future planning, and analytics. Tom comes to us with more than 25 years’ experience building and leading organizations including over ten years within the healthcare industry. Tom operated as the CFO for The MEDLAB, American Health Associates and most recently Revecore, a private equity funded revenue cycle management company serving hospitals and health systems nationwide. As Sequoia’s VP of Commercial Operations, Chan is responsible for leading business development. As part of the Genentech/Roche Global Engineering leadership team, Steve led GMP manufacturing capital projects at multiple Genentech sites around the world.